STAT News

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.

By STAT News

1 min read
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights